{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:35:32Z","timestamp":1783568132250,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005153","name":"China National Funds for Distinguished Young Scientists","doi-asserted-by":"publisher","award":["Grant No.82073324"],"award-info":[{"award-number":["Grant No.82073324"]}],"id":[{"id":"10.13039\/501100005153","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1245\/s10434-022-12348-9","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T19:02:44Z","timestamp":1659985364000},"page":"8551-8563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative Study of the Efficacy and Safety of Radical Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy in Locally Advanced Gastric Cancer: A Propensity Score-Matching Analysis"],"prefix":"10.1245","volume":"29","author":[{"given":"Chu","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xikai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianshi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouyuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixiong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"12348_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin."},{"key":"12348_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NCT, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"12348_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/14737140.2020.1781620","volume":"20","author":"K Harada","year":"2020","unstructured":"Harada K, Zhao M, Shanbhag N, Baba H, Ajani JA. Palliative care for advanced gastric cancer. Expert Rev Anticancer Ther. 2020;20:575\u201380.","journal-title":"Expert Rev Anticancer Ther."},{"key":"12348_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejso.2020.10.006","volume":"47","author":"A Brandl","year":"2021","unstructured":"Brandl A, Yonemura Y, Glehen O, Sugarbaker P, Rau B. Long-term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: a multi-institutional cohort from PSOGI. Eur J Surg Oncol. 2021;47:172\u201380.","journal-title":"Eur J Surg Oncol."},{"key":"12348_CR5","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"P-E Bonnot","year":"2019","unstructured":"Bonnot P-E, Piessen G, Kepenekian V, Decullier E. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37:2028\u201340.","journal-title":"J Clin Oncol."},{"key":"12348_CR6","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3390\/cancers11111662","volume":"11","author":"AC Gamboa","year":"2019","unstructured":"Gamboa AC, Winer JH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer. Cancers. 2019;11:1662.","journal-title":"Cancers"},{"key":"12348_CR7","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00423-021-02137-5","volume":"406","author":"F Rosa","year":"2021","unstructured":"Rosa F, Galiandro F, Ricci R, Di Miceli D, Longo F, Quero G, et al. Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center. Langenbecks Arch Surg. 2021;406:1071\u201380.","journal-title":"Langenbecks Arch Surg."},{"key":"12348_CR8","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.ejso.2019.07.030","volume":"45","author":"MY Reutovich","year":"2019","unstructured":"Reutovich MY, Krasko OV, Sukonko OG. Hyperthermic intraperitoneal chemotherapy in serosa-invasive gastric cancer patients. Eur J Surg Oncol. 2019;45:2405\u201311.","journal-title":"Eur J Surg Oncol."},{"key":"12348_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/jso.22017","volume":"104","author":"RS Gill","year":"2011","unstructured":"Gill RS, Al-Adra DP, Nagendran J, Campbell S, Shi X, Haase E, et al. Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. J Surg Oncol. 2011;104:692\u20138.","journal-title":"J Surg Oncol."},{"key":"12348_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378:230\u201340.","journal-title":"N Engl J Med."},{"key":"12348_CR11","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s13304-020-00788-5","volume":"72","author":"A Di Leo","year":"2020","unstructured":"Di Leo A, Corvasce A, Weindelmayer J, Mason EJ, Casella F, de Manzoni G. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study. Updates Surg. 2020;72:1207\u201312.","journal-title":"Updates Surg."},{"key":"12348_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/annonc\/mdl428","volume":"18","author":"TD Yan","year":"2007","unstructured":"Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007;18:827\u201334.","journal-title":"Ann Oncol."},{"key":"12348_CR13","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1245\/s10434-019-07450-4","volume":"26","author":"I Manzanedo","year":"2019","unstructured":"Manzanedo I, Pereira F, Rihuete Caro C, Perez-Viejo E, Serrano A, Gutierrez Calvo A, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal carcinomatosis: multicenter study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). Ann Surg Oncol. 2019;26:2615\u201321.","journal-title":"Ann Surg Oncol."},{"key":"12348_CR14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/00000658-199011000-00005","volume":"212","author":"S Fujimoto","year":"1990","unstructured":"Fujimoto S, Shrestha RD, Kokubun M. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg. 1990;212:592\u20136.","journal-title":"Ann Surg."},{"key":"12348_CR15","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1186\/s12885-019-6125-z","volume":"19","author":"MK Beeharry","year":"2019","unstructured":"Beeharry MK, Zhu ZL, Liu WT, Yao XX, Yan M, Zhu ZG. Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study. BMC Cancer. 2019;19:932.","journal-title":"BMC Cancer."},{"key":"12348_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12885-021-07925-2","volume":"21","author":"B Fan","year":"2021","unstructured":"Fan B, Bu Z, Zhang J, Zong X, Ji X, Fu T, et al. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery. BMC Cancer. 2021;21:216.","journal-title":"BMC Cancer."},{"key":"12348_CR17","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1245\/s10434-010-1362-z","volume":"17","author":"K Washington","year":"2010","unstructured":"Washington K. 7th Edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077\u20139.","journal-title":"Ann Surg Oncol."},{"key":"12348_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ijsu.2015.04.079","volume":"18","author":"NJ Hackett","year":"2015","unstructured":"Hackett NJ, De Oliveira GS, Jain UK, Kim JY. ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int J Surg. 2015;18:184\u201390.","journal-title":"Int J Surg."},{"key":"12348_CR19","first-page":"198","volume":"42","author":"Y Li","year":"2015","unstructured":"Li Y, Zhou Y, Liang H, Wang H, Hao J, Zhu Z, et al. Expert consensus on cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for the treatment of peritoneal surface tumors. Chin Oncol Clin. 2015;42:198\u2013206.","journal-title":"Chin Oncol Clin."},{"key":"12348_CR20","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.2147\/CMAR.S249838","volume":"12","author":"Y Zhong","year":"2020","unstructured":"Zhong Y, Zhang J, Bai X, Sun Y, Liu H, Ma S, et al. Lobaplatin in prophylactic hyperthermic intraperitoneal chemotherapy for advanced gastric cancer: safety and efficacy profiles. Cancer Manag Res. 2020;12:5141\u20136.","journal-title":"Cancer Manag Res."},{"key":"12348_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317714626","author":"Z Song","year":"2017","unstructured":"Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017. https:\/\/doi.org\/10.1177\/1010428317714626.","journal-title":"Tumour Biol."},{"key":"12348_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12885-015-1081-8","volume":"15","author":"F Seyfried","year":"2015","unstructured":"Seyfried F, von Rahden BH, Miras AD, Gasser M, Maeder U, Kunzmann V, et al. Incidence, time course, and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin: a longitudinal experience from a prospectively collected database of 1108 patients. BMC Cancer. 2015;15:73.","journal-title":"BMC Cancer."},{"key":"12348_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U","volume":"61","author":"S Koga","year":"1988","unstructured":"Koga S. Prophylactic cancer therapy for peritoneal recurrence of gastric by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer. 1988;61:232\u20137.","journal-title":"Cancer"},{"key":"12348_CR24","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17:2370\u20137.","journal-title":"Ann Surg Oncol."},{"key":"12348_CR25","first-page":"106","volume":"57","author":"Y Kusakac","year":"1990","unstructured":"Kusakac Y. Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis. Oncology. 1990;57:106\u201314.","journal-title":"Oncology."},{"key":"12348_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1067\/msy.2002.123769","volume":"131","author":"C Kunisaki","year":"2002","unstructured":"Kunisaki C, Shimada H, Nomura M, Akiyama H, Takahashi M, Matsuda G. Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer. Surgery. 2002;131:521\u20138.","journal-title":"Surgery."},{"key":"12348_CR27","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.7314\/APJCP.2012.13.9.4379","volume":"13","author":"JY Huang","year":"2012","unstructured":"Huang JY, Xu YY, Sun Z, Zhu Z, Song YX, Guo PT, et al. Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis. Asian Pac J Cancer Prev. 2012;13:4379\u201385.","journal-title":"Asian Pac J Cancer Prev."},{"key":"12348_CR28","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1245\/s10434-007-9429-1","volume":"14","author":"S Kusamura","year":"2007","unstructured":"Kusamura S, Baratti D, Younan R, Laterza B, Oliva GD, Costanzo P, et al. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity. Ann Surg Oncol. 2007;14:2550\u20138.","journal-title":"Ann Surg Oncol."},{"key":"12348_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1245\/s10434-019-07495-5","volume":"27","author":"RJ Hendrix","year":"2020","unstructured":"Hendrix RJ, Kassira JP, Lambert LA. Elevated maximum core body temperature during hyperthermic intraperitoneal chemoperfusion (HIPEC) is associated with increased postoperative complications. Ann Surg Oncol. 2020;27:232\u20139.","journal-title":"Ann Surg Oncol."},{"key":"12348_CR30","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1016\/S0140-6736(15)00981-2","volume":"387","author":"DI Sessler","year":"2016","unstructured":"Sessler DI. Perioperative thermoregulation and heat balance. Lancet. 2016;387:2655\u201364.","journal-title":"Lancet"},{"key":"12348_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7819-12-1","volume":"12","author":"MT Ganter","year":"2014","unstructured":"Ganter MT. Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. World J Surg Oncol. 2014;12:1\u20139.","journal-title":"World J Surg Oncol."},{"key":"12348_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s101200100013","volume":"4","author":"H-S Bae","year":"2001","unstructured":"Bae H-S. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer. 2001;4:27\u201333.","journal-title":"Gastric Cancer."},{"key":"12348_CR33","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3390\/jcm8101685","volume":"8","author":"HJF Brenkman","year":"2019","unstructured":"Brenkman HJF, Paeva M, van Hillegersberg R, Ruurda JP, Haj Mohammad N. Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer: a systematic review. J Clin Med. 2019;8:1685.","journal-title":"J Clin Med."},{"key":"12348_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","volume":"79","author":"J Desiderio","year":"2017","unstructured":"Desiderio J, Chao J, Melstrom L, Warner S, Tozzi F, Fong Y, et al. The 30-year experience: a meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer. 2017;79:1\u201314.","journal-title":"Eur J Cancer."},{"key":"12348_CR35","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.11.5.1081","author":"M Ikeguchi","year":"1997","unstructured":"Ikeguchi M, Maeta M, Kaibara N. Therapeutic value of intraperitoneal hyperthermic peritoneal perfusion for patients with gastric cancer. Int J Oncol. 1997. https:\/\/doi.org\/10.3892\/ijo.11.5.1081.","journal-title":"Int J Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12348-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12348-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12348-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T20:07:04Z","timestamp":1667851624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12348-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":35,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["12348"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12348-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,8]]},"assertion":[{"value":"19 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Wuhan Union Medical College Hospital as [2021] LUNSHENGZI (0677). The study was performed in accordance with the Declaration of Helsinki","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"There are no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}